Author

Moritz Berger

Observed name: Berger, Moritz

OpenAlex ID: A5146722282

Evaluating Sorafenib (SORA-2) as Second-Line Treatment for Unresectable Hepatocellular Carcinoma: A European Retrospective Multicenter Study

2025 · Möhring, Christian, Berger, Moritz, et al. · Cancers

Works count: 2

Citation count:

H-index:

I10-index: